Concepedia

Publication | Closed Access

Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases

DOI

21

Citations

26

References

2017

Year

H. Kim, Malolan S. Rajagopalan, Sushil Beriwal, Kenneth J. Smith
Clinical Oncology

References

YearCitations

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

Eric L. Chang, Jeffrey S. Wefel, Kenneth R. Hess,

The Lancet Oncology

2009

2.4K

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

David W. Andrews, Charles Scott, Paul W. Sperduto,

The Lancet

2004

2.4K

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases

Hidefumi Aoyama, Hiroki Shirato, Masao Tago,

JAMA

2006

2.2K

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Martin Köcher, Riccardo Soffietti, Ufuk Abacıoğlu,

Journal of Clinical Oncology

2010

2K

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

Paul D. Brown, Kurt A. Jaeckle, Karla V. Ballman,

JAMA

2016

1.6K

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

A. Laupacis, David Feeny, Allan S. Detsky,

PubMed

1992

1.6K

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study

Masaaki Yamamoto, Toru Serizawa, Takashi Shuto,

The Lancet Oncology

2014

1.4K

A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results

Riccardo Soffietti, Martin Köcher, Ufuk Abacıoğlu,

Journal of Clinical Oncology

2012

637

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

R. Scott Braithwaite, David Meltzer, Joseph T. King,

Medical Care

2008

584

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

May Tsao, Dirk Rades, Andrew Wirth,

Practical Radiation Oncology

2012

583

Page 1